| Stage | SYK | % of rev | INFU | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.5B | 100.00% | $37M | 100.00% | SYK ×176.54 |
| Gross profit | $4.2B | 65.15% | $21M | 57.98% | SYK +7.2pp |
| Operating income | $1.0B | 15.86% | $4M | 11.24% | SYK +4.6pp |
| Pre-tax income | $997M | 15.29% | $4M | 10.48% | SYK +4.8pp |
| Net income | $753M | 11.55% | $3M | 8.75% | SYK +2.8pp |
| Stage | SYK | INFU | Gap · A − B |
|---|---|---|---|
| Revenue | $6.5B100.00% | $37M100.00% | SYK ×176.54 |
| Gross profit | 65.15%$4.2B | 57.98%$21M | SYK +7.2pp |
| Operating income | 15.86%$1.0B | 11.24%$4M | SYK +4.6pp |
| Pre-tax income | 15.29%$997M | 10.48%$4M | SYK +4.8pp |
| Net income |
| 11.55%$753M |
| 8.75%$3M |
| SYK +2.8pp |
No shared counterparties.